Deflation Reaches a New High: 42,008.06 DMD Permanently Burned via Smart Contract Last Week
[June 11, 2026] The latest on-chain data from the DMDAO Intelligent Computing Center indicates that within the past 7 calendar days, the DMD smart contract has automatically captured and executed the physical burning of a total of 42,008.06 DMD, setting a recent record for the highest weekly deflation volume.
Accelerating Toward the One-Million Total Supply Cap: The full outbreak of this round of burning is driving DMD to accelerate its convergence toward its ultimate scarcity limit of 1,000,000 tokens. With the surge in network-wide interactions, the circulating supply in the market is undergoing a deeper structural tightening.
A Direct Reflection of Market-Making Yields: The explosion in burning data directly reflects the strong high-frequency spread capturing capabilities and authentic business revenues of the underlying Matrix Prime market-making system. Powered by the Euler linear deflation model, the reduction in total circulating supply simultaneously strengthens the algorithmic weight of the remaining tokens.
Code Rigidity Defying Market Sentiments: DMDAO official stated that the deflation of DMD does not rely on market sentiment, but is instead a long-term mechanism built purely upon real transaction flows, the internal loop of market-making yields, and automated contract execution. Every burn serves as on-chain ironclad evidence of the economic model's highly efficient operation.
Deflation continues, structure reshapes.
Genesis nodes concluded; DMDAO officially enters the era of pure zero-sum game among existing stock!
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
